Pharmafile Logo
Pharmafocus logo
Advanced Search

Ikervis

Showing 3 posts of 3 posts found.

New final NICE guidance on AbbVie, BMS, Pfizer and Roche drugs

December 16, 2015
Sales and Marketing BioMarin Pharma, Enbrel, Humira, Ikervis, MPS IVa, NICE, NICE guidance, Orencia, RoActemra, Santen, apremilast, ciclosporin, dry eye syndrome, juvenile idiopathic arthritis, otezla, psoriatic arthritis, vimizin

NICE has published final guidance on several drugs, approving therapies for juvenile idiopathic arthritis, dry eye disease and Morquio A …

News
Ikervis

New treatments to boost dry eye drug market – if approved

November 5, 2015
Sales and Marketing Allergan, Ikervis, Restasis, Shire, cyclosporine, dry eye disease, dry eye syndrome, lifitegrast

The global market for treatments for dry eye syndrome will double in value to an estimated $4.6 billion by 2024, …

News

NICE asks for more evidence from dry eye treatment maker

June 24, 2015
Research and Development, Sales and Marketing Ikervis, NHS, NICE, ciclosporin, santen pharma

A NICE appraisal committee has asked for more information on a treatment for chronic dry eye syndrome, after failing to …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024